4 months on fin, adding topical min
    Is this regrowth? 5/2/2026

    From the encyclopedia
    Finasteride →

    Popular 5-alpha reductase inhibitor that lowers DHT, taken as a pill or used topically

    Ketoconazole →

    Antifungal, best known as a dandruff shampoo

    Minoxidil →

    Vasodilator used on the scalp and, at low doses, as a tablet

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    💊 Finasteride (oral) 1mg every other day 4 months
    💧 Ketoconazole (topical)
    💧 Minoxidil (topical)
    the tone is 😐 neutral with some growth results.

    Other terms

    A user in their 40s is using finasteride every other day and ketoconazole shampoo for hair loss, considering adding topical minoxidil for further regrowth, including on eyebrows. They are advised to continue with the current regimen for a few more months before reassessing and to be cautious with minoxidil due to its application challenges and potential risks to pets.
    View this post in the Community →

    Similar Community Posts Join

    5 / 5 results

    Related Research

    6 / 6 results

      research Overactive bladder in men

      1 citations , January 2009 in “CRC Press eBooks”
      This chapter discusses the increasing prevalence of overactive bladder in aging men, examining potential causes and treatment options, without reporting new clinical results.

      research Management of Hair Loss

      74 citations , April 2005 in “Dermatologic Clinics”
      This article reviews treatment options for male-pattern and female-pattern hair loss, telogen effluvium, and alopecia areata, but provides no new clinical results; algorithmic management approaches are included.

      research Male pattern baldness: current treatments, future prospects

      40 citations , July 2008 in “Drug Discovery Today”
      This review addresses the limited efficacy of current treatments for male pattern baldness and explains that emerging genetic insights could lead to more effective future therapies.